Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Cash from Investing Activities (2016 - 2026)

Dexcom has reported Cash from Investing Activities over the past 17 years, most recently at -$298.5 million for Q1 2026.

  • Quarterly Cash from Investing Activities fell 397.9% to -$298.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $137.3 million through Mar 2026, up 175.4% year-over-year, with the annual reading at $536.0 million for FY2025, 358.31% up from the prior year.
  • Cash from Investing Activities was -$298.5 million for Q1 2026 at Dexcom, down from $306.6 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $414.9 million in Q4 2023 and troughed at -$555.9 million in Q2 2023.
  • The 5-year median for Cash from Investing Activities is -$144.9 million (2022), against an average of -$58.7 million.
  • Year-over-year, Cash from Investing Activities surged 690.69% in 2022 and then tumbled 397.9% in 2026.
  • A 5-year view of Cash from Investing Activities shows it stood at -$194.1 million in 2022, then surged by 313.76% to $414.9 million in 2023, then tumbled by 173.2% to -$303.7 million in 2024, then skyrocketed by 200.95% to $306.6 million in 2025, then crashed by 197.36% to -$298.5 million in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Cash from Investing Activities are -$298.5 million (Q1 2026), $306.6 million (Q4 2025), and $192.8 million (Q3 2025).